Health Education for Improving Health Behaviors

Overseen By Kelsey Van Brocklin, BS

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Oregon

Disqualifiers: Language barrier, Previous enrollment

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

600 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial aims to help Latinx individuals in Oregon feel better about accepting health advice and taking actions like COVID-19 testing. The intervention involves a short exercise where participants think positively about themselves. This approach is expected to make them more open to health messages and reduce barriers like discrimination and mistrust.

Research Team

Dave DeGarmo, PhD

Principal Investigator

University of Oregon

Eligibility Criteria

This trial is for adults over the age of 18 who are attending a Mexican Consulate event that the research team is also attending. It aims to engage with Latinx communities and address COVID-19 health disparities.

Inclusion Criteria

Attending a Mexican Consulate event that our team is attending

I am 18 years old or older.

Exclusion Criteria

Individual has previously enrolled in the research project

I can understand English, Spanish, or another translated language at a basic level.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

1 visit (in-person)

Pilot Testing

Pilot test rapid SARS-CoV-2 test distribution and SAII intervention in Spanish and English

3 months

Multiple visits (in-person and virtual)

Clustered Randomized Trial

Conduct a clustered randomized trial to test the effectiveness of the SAII intervention on testing and vaccine acceptance

6 months

Multiple visits (in-person at events)

Follow-up

Participants are monitored for changes in vaccine acceptance and health behaviors

1 month

1 visit (virtual)

Treatment Details

Interventions

• Promotores de Salud (Health Education)
• Self-Affirmation Implementation Intentions (SAII) Intervention

Trial Overview The study tests a behavioral intervention called Self-Affirmation Implementation Intentions (SAII) alongside Promotores de Salud, which is health education provided by community health workers, to see if they improve health behaviors and reduce vaccine hesitancy among Latinx populations.

Participant Groups

Group I: Self-Affirmation Implementation Intentions (SAII) intervention (plus Promotores Health Education) Experimental Treatment 2 Interventions

The SAII is designed to reduce stigma and enhance uptake of health messaging. SAII couples; (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance.

Group II: Promotores Health Education only condition Active Control 1 Intervention

The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation. When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.

Who Is Running the Clinical Trial?

University of Oregon

Lead Sponsor

Trials

91

Recruited

46,700+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials

473

Recruited

1,374,000+